البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)
Insulin human
Sanofi
Insulin human
100unit/1ml
Solution for injection
Subcutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF:
541551 اقرأ الوثيقة كاملة541551 SAP-NR. (DMC): 541551 SCHRIFTGRÖSSE: 9 PUNKT DRUCKFARBEN: PANTONE REFLEX BLUE FORMAT 420 X 296 MM ERSTELLT AM: 04. MAI 2018 / VERSION: 3 / MAC 541551 READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor, pharmacist or nurse. – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. – If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. Special patient groups If you have liver or kidneys problems or if you are elderly, speak to your doctor as you may need a lower dose. Travel Before travelling, consult your doctor. You may need to talk about – the availability of your insulin in the country you are visiting, – supplies of insulin, injection syringes etc., – correct storage of your insulin while travelling, – whom to contact in the event of technical problems with your pump, – timing of meals and insulin administration while travelling, – the possible effects of changing to different time zones, – possible new health risks in the countries to be visited, – what you should do in emergency situations when you feel unwell or become ill. Illnesses and injuries. In the following situations, the management of your diabetes may require a lot of care: – If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia). – If you are not eating enough, your blood sugar level may become too low (hypoglycaemia). In most cases you will need a doctor. MAKE SURE THAT YOU CONTACT A DOCTOR EARLY. If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you tha
OBJECT 1 INSUMAN INFUSAT 100 IU/ML SOLUTION FOR INJECTION IN A VIAL Summary of Product Characteristics Updated 16-May-2018 | SANOFI 1. Name of the medicinal product Insuman Infusat 100 IU/ml solution for injection in a vial Insuman Infusat 100 IU/ml solution for injection in a cartridge 2. Qualitative and quantitative composition Insuman Infusat 100 IU/ml in a vial Each ml contains 100 IU insulin human (equivalent to 3.5 mg). Each vial contains 10 ml of solution for injection, equivalent to 1000 IU insulin. Insuman Infusat 100 IU/ml in a cartridge Each ml contains 100 IU insulin human (equivalent to 3.5 mg). Each cartridge contains 3.15 ml of solution for injection, equivalent to 315 IU insulin. One IU (International Unit) corresponds to 0.035 mg of anhydrous human insulin * . Insuman Infusat is a neutral insulin solution (regular insulin). * Human insulin is produced by recombinant DNA technology in _Escherichia coli_. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Solution for injection . Clear, colourless solution. 4. Clinical particulars 4.1 Therapeutic indications Diabetes mellitus where treatment with insulin is required. 4.2 Posology and method of administration Posology Insuman Infusat has been specially designed for use in external portable insulin pumps. It is specially stabilised to minimise loss of efficacy which may result from mechanical and thermal stress in such pumps. Insuman Infusat is therefore also suitable for continuous insulin infusion with other, conventional injection syringe pumps. The desired blood glucose levels and the insulin dose regimen must be determined individually and adjusted to suit the patient's diet, physical activity and life-style. _Daily doses and timing of administration _ When used in external portable insulin pumps, part of the daily insulin dose is infused continuously ("basal rate"), and the rest is administered in the form of bolus injections before meals. Refer to the operating instructions for detailed information about the infusion pump اقرأ الوثيقة كاملة